thromboxanes has been researched along with Anasarca in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frey, M; Herndon, DH; Jeschke, MG; Kamolz, LP; Keck, M | 1 |
| Knights, KM; Mangoni, AA | 1 |
| Alexander, F; Hechtman, HB; Huval, WV; Lelcuk, S; Mathieson, M; Shepro, D; Teoh, KH; Valeri, CR | 1 |
| Dunham, BM; Hechtman, HB; Huval, WV; Lelcuk, S; Shepro, D; Valeri, CR | 1 |
| Dorsch, W; Melzer, H; Ring, J | 1 |
| Giroud, JP; Hazebroucq, G; Postaire, E; Regnault, C; Roch-Arveiller, M; Sarfati, G; Tissot, M | 1 |
| Featherstone, RL; Uhlig, S; Wendel, A; Wilhelms, OH | 1 |
| Makino, S | 1 |
3 review(s) available for thromboxanes and Anasarca
| Article | Year |
|---|---|
Pathophysiology of burns.
Topics: Angiotensin II; Animals; Burns; Catecholamines; Edema; Hemodynamics; Histamine; Humans; Hypovolemia; Inflammation Mediators; Platelet Activating Factor; Prostaglandins; Serotonin; Skin; Soft Tissue Injuries; Thromboxanes; Vascular Resistance; Vasopressins | 2009 |
[Non-steroidal anti-inflammatory drugs and risk of stroke in older patients: current controversies and research directions].
Topics: Age Factors; Aged; Aged, 80 and over; Aldosterone; Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Comorbidity; Cyclooxygenase 2 Inhibitors; Disease Progression; Drug Interactions; Edema; Epoprostenol; Evidence-Based Medicine; Forecasting; Humans; Hypertension; Kidney; Research; Risk; Stroke; Thrombophilia; Thromboxanes | 2011 |
[Physiological and pharmacological actions of prostaglandins and related substances: inflammation and allergy].
Topics: Animals; Arachidonic Acids; Arthritis, Rheumatoid; Edema; Eosinophils; Guinea Pigs; Humans; Hypersensitivity; Leukotriene B4; Mast Cells; Mice; Muscle Contraction; Nephritis; Prostaglandin D2; Prostaglandins; Prostaglandins D; Rabbits; Rats; Receptors, Fc; Receptors, IgE; Receptors, Immunologic; SRS-A; Thromboxanes | 1985 |
1 trial(s) available for thromboxanes and Anasarca
| Article | Year |
|---|---|
A selective inhibitor of thromboxane biosynthesis enhances immediate and inhibits late cutaneous allergic reactions in man.
Topics: Adult; Antibodies, Anti-Idiotypic; Dose-Response Relationship, Immunologic; Edema; Humans; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Imidazoles; Immunoglobulin E; Intradermal Tests; Respiratory Hypersensitivity; Thromboxanes | 1983 |
4 other study(ies) available for thromboxanes and Anasarca
| Article | Year |
|---|---|
Arachidonic acid metabolites mediate early burn edema.
Topics: Animals; Body Water; Burns; Calcium Channel Blockers; Capillary Permeability; Chromones; Edema; Ibuprofen; Ketoconazole; Male; Oxamic Acid; Rats; Rats, Inbred Strains; SRS-A; Thromboxanes | 1984 |
Thromboxane mediation of cardiovascular dysfunction following aspiration.
Topics: Animals; Capillary Permeability; Cardiac Output; Cardiovascular System; Cricetinae; Dogs; Edema; Hemodynamics; Hydrochloric Acid; Imidazoles; Inhalation; Ketoconazole; Leukocytes; Lung; Papillary Muscles; Piperazines; Respiration; Thromboxane B2; Thromboxanes; Time Factors | 1983 |
Effect of encapsulation on the anti-inflammatory properties of superoxide dismutase after oral administration.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cattle; Ceramides; Dinoprostone; Drug Carriers; Drug Compounding; Edema; Exudates and Transudates; Leukocyte Count; Liposomes; Male; Neutrophils; Pleurisy; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Superoxides; Thromboxanes | 1995 |
Effect of urodilatin on platelet-activating factor-induced bronchoconstriction, vasoconstriction and edema formation in isolated rat lung.
Topics: Analysis of Variance; Animals; Atrial Natriuretic Factor; Bronchoconstriction; Bronchodilator Agents; Capillary Permeability; Edema; Female; Lung; Organ Size; Peptide Fragments; Perfusion; Platelet Activating Factor; Rats; Rats, Wistar; Thromboxanes; Vascular Resistance; Vasoconstriction | 1996 |